Inflammatory mechanisms of diabetic complications

被引：178

作者：

Williams M.D. ^{[1
]}

Nadler J.L. ^{[1
]}

机构：

[1] Division of Endocrinology and Metabolism, University of Virginia, Charlottesville, VA 22908-1405

来源：

Current Diabetes Reports | 2007年 / 7卷 / 3期

基金：

美国国家卫生研究院;

关键词：

Diabetic Nephropathy; Diabetic Retinopathy; Vascular Smooth Muscle Cell; Arterioscler Thromb Vasc Biol; Human Aortic Endothelial Cell;

D O I：

10.1007/s11892-007-0038-y

中图分类号：

学科分类号：

摘要：

Activation of inflammatory process may contribute to the development of type 2 diabetes mellitus. In addition, inflammation appears to be a major mechanism responsible for vascular damage leading to the clinically well-recognized complications of diabetes. Inflammation cytokine and chemokine mediators released from visceral fat contribute to atherosclerosis plaque formation and increased risk for myocardial infarction and stroke. Activation of growth factors and adhesion molecules may promote the movement of inflammatory cells into the renal microvasculature, predisposing to the development of diabetic nephropathy. Emerging evidence also indicates that markers of inflammation are associated with the more severe forms of diabetic retinopathy. Future approaches to the treatment of diabetic complications may involve regulation of inflammatory processes, specifically targeting factors that contribute to vascular damage. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：242 / 248

页数：6

共 69 条

[1]

National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005, (2005)

[2]

Ogden C.L., Carroll M.D., Curtin L.R., Et al., Prevalence of overweight and obesity in the United States, 1999-2004, JAMA, 295, pp. 1549-1555, (2006)

[3]

Brownlee M., The pathobiology of diabetic complications: A unifying mechanism, Diabetes, 54, pp. 1615-1625, (2005)

[4]

Rask-Madsen C., King G., Mechanisms of disease: Endothelial dysfunction in insulin resistance and diabetes, Nat Clin Pract Endocrinol Metab, 3, pp. 46-56, (2007)

[5]

Yan S., Yan S., Herold K., Et al., Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: Lessons from AGEing, Endocrinol Metab Clin North Am, 35, pp. 511-524, (2006)

[6]

Kern P.A., Ranganathan S., Li C., Et al., Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance, Am J Physiol Endocrinol Metab, 280, (2001)

[7]

Yudkin J.S., Stehouwer C.D.A., Emeis J.J., Coppack S.W., C-Reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?, Arterioscler Thromb Vasc Biol, 19, pp. 972-978, (1999)

[8]

Trujillo M.E., Scherer P.E., Adipose tissue-derived factors: Impact on health and disease, Endocr Rev, 27, pp. 762-778, (2006)

[9]

Maedler K., Sergeev P., Ris F., Et al., Glucose-induced beta cell production of IL-1 beta contributes to glucotoxicity in human pancreatic islets, J Clin Invest, 110, pp. 851-860, (2002)

[10]

Robertson R.P., Oxidative stress and impaired insulin secretion in type 2 diabetes, Curr Opin Pharmacol, 6, pp. 615-619, (2006)

← 1 2 3 4 5 6 7 →